Cesar Velarde, MD
Interventional Pain Medicine · Las Cruces, NMNPI 1588633655
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,130 of the $3,322 with a category attached, or 64.1%. Abbott accounts for 60.1% of it on its own, with 6 other manufacturers making up the rest.
Across 82 payments — averaging $40.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Boston Scientific$1K
- Medtronic$78
- Averitas Pharma Inc.$49
- Scilex Pharmaceuticals Inc.$46
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$36
- plus $33 from 1 others
What the payments were for
- Travel & lodging$1,19236%
- Food & beverage$2,13064%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 50 | $1,995 |
| Boston Scientific | 20 | $1,086 |
| Medtronic(2 entities) | 4 | $78 |
| Averitas Pharma Inc. | 2 | $49 |
| Scilex Pharmaceuticals Inc. | 3 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| Nevro Corp. | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few interventional pain medicine providers in New Mexicoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Las Cruces
- Jose RamirezLas Cruces$714
- Reuel MeasomAlbuquerque$49K
- Diego GonzalezAlbuquerque$35K
- Athanasios ManoleAlbuquerque$9K
- Craig NairnAlbuquerque$4K
- Edward PoonAlbuquerque$2K
- Kyle SchoenbergerAlbuquerque$2K
- Michael MalizzoAlbuquerque$462
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.